StockData
Kiora Pharmaceuticals Inc logo

Kiora Pharmaceuticals Inc (KPRX) stock

KPRXNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as KPHMW
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 7/30
$0.93−0.05 (-5.30%)

Close on Nov 17, 2026Market cap $4.11MP/E –Yield –

Kiora Pharmaceuticals operating margin

Operating margin is operating income as a percentage of revenue.

Kiora Pharmaceuticals's operating margin for the twelve months ending Mar 31, 2025 was -55210.8%. For fiscal 2024 it was 28.2%, against -56960.5% the year before.

Annual operating margin

PeriodPeriod endValueChange (pts)
FY2024Dec 31, 202428.2%+56988.7
FY2020Dec 31, 2020-56960.5%−56304.3
FY2018Dec 31, 2018-656.3%–

Quarterly operating margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2024Jun 30, 2024-12724.4%−11714.0
Q1 FY2024Mar 31, 202482.6%+1238.9
Q4 FY2020Dec 31, 2020-9698.8%−9481.7
Q1 FY2019Mar 31, 201930.9%+5573.5
Q3 FY2018Sep 30, 2018-1010.5%+1233.0
Q2 FY2018Jun 30, 2018-1156.3%+425.9
Q1 FY2018Mar 31, 2018-217.1%+1014.1
Q3 FY2017Sep 30, 2017-5542.6%–
Q2 FY2017Jun 30, 2017-2243.4%–
Q1 FY2017Mar 31, 2017-1582.2%–
Q3 FY2016Sep 30, 2016-1231.2%–

More Kiora Pharmaceuticals figures

See a number that looks wrong?